| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
06-13-2019, 08:42 PM
|
#8 | ||
|
|||
|
Member
|
Thanks for the link, ashleyk.
As it says in your linked article, "CuATSM is a small artificial molecule [that contains a copper atom,] that is able to deliver copper to cells containing damaged mitochondria ...". As it says in the Conclusions section of the PD Phase 1 abstract (see link above): "Based on treatment tolerance and improvement in UPDRS and PDQ-39 over 24 weeks at [recommended dose], further development in a randomized, placebo-controlled trial is justified." |
||
|
 Reply With Quote
|
| "Thanks for this!" says: | RooJr (06-15-2019) |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Trial raises Parkinson's therapy hope - BBC News | Parkinson's News | |||
| Caffeine for treatment of Parkinson disease: A randomized controlled trial. | Parkinson's Disease | |||
| Australian report:Parkinson's disease up 17% | Parkinson's Disease | |||
| Freed: New hope for Parkinson's treatment | Parkinson's Disease | |||
| Hope For New Parkinson's Disease Treatment Through RXR Activation | Parkinson's Disease | |||
Threaded Mode